Because CD8+ T cells specific for protective HIV-1 epitopes can effectively suppress HIV-1 replication in vivo, it is expected that the identification of protective T cell epitopes will contribute to the development of AIDS vaccines and HIV-1 cures. This evidence concerns the gene CD8A and AIDS.